Bio-sight Capital
6
4M
4
0.30
1
0.33
2
- Areas of investment
Summary
Bio-sight Capital is the famous VC, which was founded in 2002. The company was established in Asia in Japan. The main office of represented VC is situated in the Osaka.
Among the most popular portfolio startups of the fund, we may highlight B-Bridge International. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Business Information Systems, Infrastructure.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Bio-sight Capital, startups are often financed by WERU Investment. The meaningful sponsors for the fund in investment in the same round are Mizuho Capital, Marubeni Corporation, Hokkaido Venture Capital.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2005.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 1
- Exits
- 2
- Rounds per year
- 0.30
- Follow on index
- 0.33
- Investments by industry
- mHealth (3)
- Medical Device (3)
- Pharmaceutical (1)
- Biotechnology (1)
- Medical (1) Show 6 more
- Investments by region
-
- Japan (5)
- United States (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 6M
- Group Appearance index
- 1.00
- Avg. company exit year
- 20
- Avg. multiplicator
- 1.02
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.